We are live on ! Find out more

2,864 hedge funds and large institutions have $92.7B invested in Pfizer in 2026 Q2 according to their latest regulatory filings, with 157 funds opening new positions, 1,171 increasing their positions, 1,232 reducing their positions, and 239 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more capital inflows, than outflows

Capital inflows: $7.48B | Capital outflows: $5.08B

1.35% more ownership

Funds ownership: 66.19% → 67.54% (+1.3%)

5% less repeat investments, than reductions

Existing positions increased: 1,171 | Existing positions reduced: 1,232

10% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $2.62B

4% less funds holding

Funds holding: 2,981 → 2,864 (-117)

34% less first-time investments, than exits

New positions opened: 157 | Existing positions closed: 239

55% less funds holding in top 10

Funds holding in top 10: 47 → 21 (-26)

Holders
2,864
Holders Change
-117
Holders Change %
-3.92%
% of All Funds
34.09%
Holding in Top 10
21
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-55.32%
% of All Funds
0.25%
New
157
Increased
1,171
Reduced
1,232
Closed
239
Calls
$2.36​B
Puts
$2.62​B
Net Calls
-⁠$259​M
Net Calls Change
-⁠$659​M

PFE Hedge Fund Activity: Q2 2026 in Review

2,864 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2026, worth a combined $92.7B — down 12% from $106B a quarter earlier.

Sellers outnumbered buyers: 239 funds closed out of PFE and 157 opened new positions — a net loss of 82 holders — while 1,232 trimmed existing stakes and 1,171 added.

The largest buyer was Royal Bank of Canada, adding an estimated $823M. The largest seller was Wellington Management Group, cutting an estimated $578M.

  • 2,864 institutional investors held Pfizer (PFE) as of Q2 2026, down from 2,981 in Q1 2026.
  • Funds reported $92.7B of Pfizer stock for Q2 2026, down 12% quarter-over-quarter.
  • 157 funds opened new Pfizer positions in Q2 2026 and 239 closed out, a net change of -82 holders.
  • The largest Pfizer buyer in Q2 2026 was Royal Bank of Canada, an estimated $823M added.
  • The largest Pfizer seller in Q2 2026 was Wellington Management Group, an estimated $578M sold.

Based on aggregated 13F filings for Q2 2026.